Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting PARP1 for treatment of TSC and cancers

Targeting PARP1 for treatment of TSC and cancers

US Patent 9987275 · Granted Jun 5, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Plug connector2020
Plug connector2020
Diagnostic and therapeutic uses of gelsolin in renal failure2019
Use of gelsolin to treat infections2018
Treatment of lymphangioleiomyomatosis2018
Diagnostic and therapeutic uses of gelsolin in renal failure2017
Method for the treatment of lymphangioleiomyomatosis (LAM)2013
Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (2013
Closed-loop feedback circuit for controlling LEDs2010
Automatic current trimming method and circuits2010